Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues 2025
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues 2025
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin

Table of Contents

August 2011; Volume 31,Issue 8

Current Aspects and Future Direction in Gynaecological Oncology

  • You have access
    Preface
    Jalid Sehouli
    Anticancer Research August 2011, 31 (8) 2565;
  • You have access
    First Evaluation of the Diagnostic Accuracy of an Automated 3D Ultrasound System in a Breast Screening Setting
    FRANK STÖBLEN, SOLVEIG LANDT, RUTH STELKENS-GEBHARDT, JALID SEHOULI, MAHDI REZAI and SHERKO KÜMMEL
    Anticancer Research August 2011, 31 (8) 2569-2574;
  • You have access
    High-frequency Breast Ultrasound for the Detection of Microcalcifications and Associated Masses in BI-RADS 4a Patients
    FRANK STÖBLEN, SOLVEIG LANDT, RAMI ISHAQ, RUTH STELKENS-GEBHARDT, MAHDI REZAI, PER SKAANE, JENS-UWE BLOHMER, JALID SEHOULI and SHERKO KÜMMEL
    Anticancer Research August 2011, 31 (8) 2575-2581;
  • You have access
    Predictive Factors in Relapsed Ovarian Cancer for Complete Tumor Resection
    BLANCA GIL-IBÁÑEZ, GULTEN OSKAY-ÖZCELIK, ROLF RICHTER, CHRISTINA FOTOPOULOU, ELENA-IOANA BRAICU, PETER NEUHAUS, WERNER LICHTENEGGER, JALID SEHOULI and On behalf of the Tumor Bank Ovarian Cancer Network (TOC) and European Competence Centre for Ovarian Cancer (EKZE Berlin)
    Anticancer Research August 2011, 31 (8) 2583-2587;
  • You have access
    Prognostic Significance of Angiogenic Factors in Uterine Cervical Cancer
    SOLVEIG LANDT, MICHAEL WEHLING, HARALD HEIDECKE, SOPHIA JESCHKE, SUSANNE KORLACH, FRANK STÖBLEN, PETER SCHMID, JENS-UWE BLOHMER, WERNER LICHTENEGGER, JALID SEHOULI and SHERKO KÜMMEL
    Anticancer Research August 2011, 31 (8) 2589-2595;
  • You have access
    CT-Guided High-Dose-Rate Brachytherapy of Metachronous Ovarian Cancer Metastasis to the Liver: Initial Experience
    FEDERICO COLLETTINI, ALEXANDER POELLINGER, DIRK SCHNAPAUFF, TIMM DENECKE, PETER WUST, IOANA ELENA BRAICU, JALID SEHOULI, BERND HAMM and BERNHARD GEBAUER
    Anticancer Research August 2011, 31 (8) 2597-2602;
  • You have access
    First Surgical Experience of Intraperitoneal Treatment with the Trifunctional Antibody Catumaxomab (Anti-EpCam × Anti-CD3) for Epithelial Ovarian Cancer
    GEORGIOS PAPANIKOLAOU, CHRISTINA FOTOPOULOU, IOANA BRAICU, RADOSLAV CHEKEROV, SVEN CHRISTIAN SCHMIDT, KLAUS PIETZNER and JALID SEHOULI
    Anticancer Research August 2011, 31 (8) 2603-2608;
  • You have access
    In Vitro Vascular Tube Formation Testing as a Tool for Treatment Individualisation in Patients with Cervical Cancer
    SOLVEIG LANDT, HARALD HEIDECKE, SUSANNE KORLACH, CORA REUTER, ILKA SCHWIDDE, JANA BARINOFF, MARC THILL, JALID SEHOULI and SHERKO KÜMMEL
    Anticancer Research August 2011, 31 (8) 2609-2615;
  • You have access
    Influence of a Dose-dense Adjuvant Chemotherapy on sVCAM-1/sICAM-1 Serum Levels in Breast Cancer Patients with 1-3 Positive Lymph Nodes
    HOLM EGGEMAN, FRANK STÖBLEN, MARC THILL, SUSANNE KORLACH, PETER SCHMID, DIANA LÜFTNER, DIRK ELLING, FLORIN-ANDREI TARAN, SHERKO KÜMMEL and SOLVEIG LANDT
    Anticancer Research August 2011, 31 (8) 2617-2622;
  • You have access
    Cell-free DNA in the Circulation as a Potential Cancer Biomarker
    CORINA KOHLER, ZEINAB BAREKATI, RAMIN RADPOUR and XIAO YAN ZHONG
    Anticancer Research August 2011, 31 (8) 2623-2628;
  • You have access
    Systemic Changes of Tryptophan Catabolites via the Indoleamine-2,3-dioxygenase Pathway in Primary Cervical Cancer
    CHRISTINA FOTOPOULOU, JALID SEHOULI, RENE PSCHOWSKI, STEPHAN VON HAEHLING, GRAZYNA DOMANSKA, ELENA-IOANA BRAICU, GERHARD FUSCH, PETRA REINKE and JOERG C. SCHEFOLD
    Anticancer Research August 2011, 31 (8) 2629-2635;
  • You have access
    Effect of Melatonin on Intra-abdominal Fat in Correlation with Endometrial Proliferation in Ovariectomized Rats
    RĂZVAN CIORTEA, NICOLAE COSTIN, IOANA BRAICU, DELIA HARAGÂŞ, AURORA HUDACSKO, COSMINA BONDOR, DAN MIHU and CARMEN MIHAELA MIHU
    Anticancer Research August 2011, 31 (8) 2637-2643;
  • You have access
    The Utility of an In Vitro Angiogenesis Score for Prognosis Assessment in Patients with Cervical Cancer
    SOLVEIG LANDT, HARALD HEIDECKE, CORA REUTER, SUSANNE KORLACH, JENS-UWE BLOHMER, WERNER LICHTENEGGER, TILL HEUSNER, FRANK STÖBLEN, MARC THILL, JANA BARINOFF, JALID SEHOULI and SHERKO KÜMMEL
    Anticancer Research August 2011, 31 (8) 2645-2649;
  • You have access
    Prognostic Significance of the Angiogenic Factors Angiogenin, Endoglin and Endostatin in Cervical Cancer
    SOLVEIG LANDT, KONSTANZE MORDELT, ILKA SCHWIDDE, JANA BARINOFF, SUSANNE KORLACH, FRANK STÖBLEN, WERNER LICHTENEGGER, JALID SEHOULI and SHERKO KÜMMEL
    Anticancer Research August 2011, 31 (8) 2651-2655;
  • You have access
    First Evaluation of the Joint Clinical Registry Data of Patients with Primary Ovarian Cancer at the Coordinating Tumor Center of Berlin
    R. CHEKEROV, S. BRAUN, A.D. EBERT, C. HERBSTREIT, A. JAGOTA, K.D. JOHANNSMEYER, C. KRONENBERGER, J. POTENBERG, J.P. SCHARF, R. RICHTER, U. ULRICH and J. SEHOULI
    Anticancer Research August 2011, 31 (8) 2657-2660;
  • You have access
    The Mutational Profile of Sporadic Epithelial Ovarian Carcinoma
    S. KALAMANATHAN, V. BATES, R. LORD and J.A. GREEN
    Anticancer Research August 2011, 31 (8) 2661-2668;
  • You have access
    Optimizing the Clinical Management of Gynecological and Breast Cancer via Online Tumor Conferences
    J.K. SCHROEDER, S. KUEMMEL, K. PIETZNER, J. HECTOR, J. SEHOULI and R. CHEKEROV
    Anticancer Research August 2011, 31 (8) 2669-2673;
  • You have access
    Long Term Combination Treatment With Bevacizumab, Pegylated Liposomal Doxorubicin and Regional Abdominal Hyperthermia in Platinum Refractory Ovarian Cancer: A Case Report and Review of the Literature
    KLAUS PIETZNER, ROSA BIANCA SCHMUCK, CHRISTINA FOTOPOULOU, JOHANNA GELLERMANN, FAKHER ISMAEEL, CHIE HEE CHO, MICHAEL KALDEN and JALID SEHOULI
    Anticancer Research August 2011, 31 (8) 2675-2677;
  • You have access
    Bevacizumab in Heavily Pre-treated and Platinum Resistant Ovarian Cancer: A Retrospective Study of the North-Eastern German Society of Gynaecologic Oncology (NOGGO) Ovarian Cancer Study Group
    KLAUS PIETZNER, ROLF RICHTER, RADOSLAV CHEKEROV, EDIBE EROL, GÜLTEN OSKAY-ÖZCELIK, WERNER LICHTENEGGER and JALID SEHOULI
    Anticancer Research August 2011, 31 (8) 2679-2682;
Back to top
PreviousNext

In this issue

Anticancer Research
Vol. 31, Issue 8
August 2011
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Sign up for alerts
  • Top Topics
  • Most Cited
  • Most Read
Loading
Role of Resveratrol in Prevention and Therapy of Cancer: Preclinical and Clinical Studies
The Association of Solar Ultraviolet B (UVB) with Reducing Risk of Cancer: Multifactorial Ecologic Analysis of Geographic Variation in Age-adjusted Cancer Mortality Rates
Epithelial−Mesenchymal Transition in EGFR-TKI Acquired Resistant Lung Adenocarcinoma
Vitamin D Supplement Doses and Serum 25-Hydroxyvitamin D in the Range Associated with Cancer Prevention
Anticancer Research

© 2025 Anticancer Research

Powered by HighWire